Home > Category > Signaling Pathways > Cytoskeletal Signaling > Integrin > Erlizumab (Anti-Integrin b2 / ITGB2 / CD18)

Erlizumab (Anti-Integrin b2 / ITGB2 / CD18)

ChemLeader 95+%
Catalog No:CLA1211 CAS No.:211323-03-4 MDLNo: Formula: MW:
Size Availability Price(USD) VIP Price (USD) Quantity
1 mg 3-5days $1300.00 Visible after login
- +
5 mg 3-5days $4000.00 Visible after login
- +
10 mg 3-5days $7600.00 Visible after login
- +
50 mg 3-5days $38000.00 Visible after login
- +

Chemical safety data sheet(MSDS)

Download MSDS
  • Product Overview
  • Related documents
  • Product details
  • Related literature
Product Overview
Product Name Erlizumab (Anti-Integrin b2 / ITGB2 / CD18)
CAS211323-03-4
Storage conditionStore at 2 to 8 °C for 1-2 weeks. Store at -20 °C for 12 months. Store at -80 °C for long term storage. Use a manual defrost freezer and avoid repeated freeze-thaw cycles, away from light.
Product details

Erlizumab (anti-Integrin b2 / ITGB2 / CD18) is a humanized monoclonal antibody targeted against Integrin beta-2 and used as a therapy for hemorrhagic shock. MW: 146.66 kD.

Related literature
Sorry, there is no relevant literature
Related
Sorry, no related items
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays